Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope, Duarte, CA, USA.
Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, Rutgers, the State University of New Jersey, New Brunswick, NJ, USA.
EMBO J. 2018 Jul 13;37(14). doi: 10.15252/embj.201796729. Epub 2018 May 17.
DNA2 is a nuclease/helicase that is involved in Okazaki fragment maturation, replication fork processing, and end resection of DNA double-strand breaks. Similar such helicase activity for resolving secondary structures and structure-specific nuclease activity are needed during DNA replication to process the chromosome-specific higher order repeat units present in the centromeres of human chromosomes. Here, we show that DNA2 binds preferentially to centromeric DNA The nuclease and helicase activities of DNA2 are both essential for resolution of DNA structural obstacles to facilitate DNA replication fork movement. Loss of DNA2-mediated clean-up mechanisms impairs centromeric DNA replication and CENP-A deposition, leading to activation of the ATR DNA damage checkpoints at centromeric DNA regions and late-S/G2 cell cycle arrest. Cells that escape arrest show impaired metaphase plate formation and abnormal chromosomal segregation. Furthermore, the DNA2 inhibitor C5 mimics DNA2 knockout and synergistically kills cancer cells when combined with an ATR inhibitor. These findings provide mechanistic insights into how DNA2 supports replication of centromeric DNA and give further insights into new therapeutic strategies.
DNA2 是一种核酸酶/解旋酶,参与冈崎片段成熟、复制叉加工和 DNA 双链断裂的末端切除。在 DNA 复制过程中,需要类似的解旋酶活性来解决二级结构问题,以及结构特异性核酸酶活性来处理人染色体着丝粒中存在的染色体特异性高重复单元。在这里,我们表明 DNA2 优先结合着丝粒 DNA。DNA2 的核酸酶和解旋酶活性对于解决 DNA 结构障碍以促进 DNA 复制叉运动都是必不可少的。失去 DNA2 介导的清除机制会损害着丝粒 DNA 的复制和 CENP-A 的沉积,导致着丝粒 DNA 区域 ATR DNA 损伤检查点的激活和晚期 S/G2 细胞周期停滞。逃避阻滞的细胞显示出中期板形成受损和染色体分离异常。此外,DNA2 抑制剂 C5 模拟 DNA2 敲除,并与 ATR 抑制剂联合使用时协同杀死癌细胞。这些发现为 DNA2 如何支持着丝粒 DNA 复制提供了机制上的见解,并为新的治疗策略提供了进一步的见解。